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Abstract
We screened an existing collection of zebrafish insertional mutants for cancer susceptibility by
histological examination of heterozygotes at two years of age. As most mutants had no altered cancer
predisposition, this provided the first comprehensive description of spontaneous tumor spectrum and
frequency in adult zebrafish. Moreover, the screen identified four lines, each carrying a different
dominant mutant allele of Hagoromo previously linked to adult pigmentation defects, which develop
tumors with high penetrance that histologically resemble neuroblastoma. These tumors are clearly
neural in origin, although they do not express catecholaminergic neuronal markers characteristic of
human neuroblastoma. The zebrafish tumors result from inappropriate maintenance of a cell
population within the cranial ganglia that are likely neural precursors. These neoplasias typically
remain small but they can become highly aggressive, initially traveling along cranial nerves, and
ultimately filling the head. The developmental origin of these tumors is highly reminiscent of human
neuroblastoma. The four mutant Hagoromo alleles all contain viral insertions in the fbxw4 gene,
which encodes an F-box WD40 domain containing protein. However, while one allele clearly reduced
the levels of fbxw4 mRNA, the other three insertions have no detectable effect on fbw4 expression.
Instead, we show that all four mutations result in the post-embryonic upregulation of the neighboring
gene, fibroblast growth factor 8 (fgf8). Moreover, fgf8 is highly expressed in the tumorigenic lesions.
While fgf8 overexpression is known to be associated with breast and prostate cancer in mammals,
this study provides the first evidence that fgf8 misregulation can lead to neural tumors.
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INTRODUCTION
The zebrafish is an increasingly popular model organism in which to study cancer (1). Mutation
of known tumor suppressors such as nf2, p53, apc, and mlh1 (2-5) result in cancer susceptibility,
and tumorigenesis can also be driven by the expression of a number of oncogenes such as c-
myc (6), mutant Kras (7) or mutant braf (8). Additionally, forward genetic screens in zebrafish
can identify novel mutations that lead to cancer susceptibility. For example, by screening
initially for mutations that affect the cell cycle in homozygous embryos, mutations in bmyb
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and separase were found to modestly increase the rate of carcinogen-induced cancer in
heterozygous adults (9,10). In another study, by conducting a pilot screen of an existing
collection of heterozygous carriers of embryonic lethal insertional mutations for the
development of externally visible spontaneous tumors, we established that haploinsufficiency
of 17 different ribosomal protein genes is highly tumorigenic (2,11). This validates the use of
zebrafish to identify novel cancer genes.
The mutant collection used for this pilot screen includes over 500 mutations in over 370 genes
(12). These mutations were made by retroviral insertion, allowing rapid identification of the
mutated gene in almost all cases by cloning the genomic DNA flanking the mutagenic insertion
(13). These mutants were recovered in a large-scale screen designed to find recessive mutations
with embryonic phenotypes (14) and nearly all of the mutants are embryonic or larval lethal
in their homozygous state. In the course of the screen we also recovered a few dominant
mutations with viable adult phenotypes affecting either pigmentation or fin growth. None of
these dominant mutations had any visible phenotypes during embryogenesis as either
heterozygotes or homozygotes.
We maintain all of the zebrafish mutant lines as stocks of 15−25 heterozygotes until two years
of age, thereby allowing for an assessment of adult phenotypes in the heterozygous state. In
this study, we have extended our analysis of the full mutant collection by screening for
spontaneous tumor development by histological examination as opposed to just externally
visible tumors. This revealed that all four alleles of the dominant mutation Hagoromo (14,
15) were highly predisposed to the development of neuroblastoma-like tumors arising in the
cranial ganglia.
RESULTS
Cancer screen of insertional mutants identifies Hagoromo
We had previously discovered that heterozygous mutation of many ribosomal protein (rp)
genes, as well as the nf2a gene (one of two paralogs of the mammalian tumor suppressor NF2)
predisposed zebrafish to the development of cancer, primarily malignant peripheral nerve
sheath tumors (2). Notably, these mutants develop tumors spontaneously, in the absence of
chemical carcinogens. While the ribosomal protein mutants generally developed large,
externally visible tumors, the nf2a heterozygotes usually developed much smaller tumors that
were only evident upon histological examination of the fish. Thus it is unlikely that we would
have discovered that these fish were tumor-prone had we not examined sections of a cohort of
apparently healthy fish. Reasoning that there might be other mutations which similarly
predisposed fish to tumors that might not be externally visible, we set about to systematically
examine heterozygotes from all of the insertional mutant lines in our collection by histology.
Initially we examined at least fifteen fish for each line at approximately two years of age. In
most cases two longitudinal sections near either side of the midline were examined, although
in some cases six sections were screened. For any families that had a tumor frequency in the
first cohort greater than background (see below), we collected additional two-year-old fish to
determine if this was a true tumor predisposition or just a sampling artifact.
All of the analyzed fish, with the exception of those from lines that we determined to be tumor-
prone, served as a control set. Analysis of these 10,000 fish from 437 lines (including mutations
in 341 different genes) indicated that the “background” frequency of tumorigenic lesions,
including pre-adenoma bile-duct hyperplasia, was about 5% at two years of age (473/9988).
The most common tumor types were seminomas and bile duct lesions (hyperplasia, adenoma,
and adenocarcinoma), followed by pancreatic islet cell adenoma and leukemia/lymphoma
(Figure 1). None of these tumor types appeared in greater than 2% of the fish and we did not
find any families in which these tumors were significantly overrepresented. As far as we are
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aware, this is the first comprehensive analysis of spontaneous tumor incidence and spectrum
in zebrafish.
Of the 342 loci screened in this manner, 339 were recessive embryonic lethal mutations.
Beyond the previously noted rp and nf2a genes, none of the heterozygous carriers of recessive
lethal mutations had a spontaneous cancer frequency significantly above background. This
included mutations in two genes, c-myb and separase, whose heterozygous mutation has been
shown to increase cancer frequency in carcinogen-treated fish (9,10). In addition to these
recessive mutations, the collection contains dominant mutations in three loci that have no
embryonic phenotype (as homozygotes or heterozygotes) but rather have viable visible adult
phenotypes either in fin growth or stripe patterning. One of these loci, for which we have four
mutant alleles, is Hagoromo (Hag). Hag mutants, named for “the dress of a goddess”, are
characterized by disorganized stripes in the adult pigment pattern that are first apparent during
the reorganization of iridophores and melanophores during metamorphosis at 3−4 weeks of
age (15). Neither heterozygotes nor homozygotes have any embryonic phenotype;
homozygotes are viable and have, on average, more severe stripe defects than heterozygotes,
sometimes resulting in a spotty appearance in the anterior flank. All four Hag alleles carry
insertions in the fbxw4 gene, which encodes an F-box containing WD-40 repeat protein (15).
Our screen revealed a significant tumor predisposition in these four Hag alleles. In each of
these lines, 25−50% of two-year-old heterozygotes had tumors that histologically resembled
neuroblastoma (Table 1, Figure 2). Importantly, these neuroblastoma-like tumors were not
observed in any of the ∼10,000 screened fish that lacked insertions in the fbxw4 gene, including
150 non-carrier siblings from the Hag families. Thus, we conclude that fish without insertions
in the Hag locus spontaneously develop this tumor type with a frequency less than 1/10,000.
This, coupled with the observation that four different insertions in this locus lead to this tumor
type, indicates that the insertions at the Hag locus are unquestionably responsible for these
cancers.
Hagoromo tumors resemble neuroblastoma and are preceded by the inappropriate
maintenance of a putative neural precursor cell population
To better understand the nature and origin of these tumors, we conducted a careful analysis of
the Hag fish. Hematoxylin and eosin staining indicated that the tumors in Hag fish indicated
that the tumors were made up of small, densely packed, oval cells with very little cytoplasm
(Figure 2). While in some tumors, cells were arranged in “rosettes” (Figure 2B) commonly
seen in partly differentiated human neuroblastoma (16), more frequently the cells were simply
present as sheets with little organization (Figure 2C) as is seen in undifferentiated human
neuroblastoma (16). The tumors were found in a wide range of sizes, from small neoplasias
(20−30 cells per planar section) to large tumors that occupied nearly the entire head, pushing
aside (though never invading) the brain and pushing into musculature of the cheeks and dorsal
body wall. The highly aggressive tumors, such as that shown in Figure 2A, were least common,
and we rarely observed fish with any external signs of tumor growth, such as a bump on the
dorsal surface or bulging of an eye. Small neoplasias were most common (Table 1) and always
arose in cranial ganglia, either just below the midbrain but still within the skull (Figure 2D) or
in ganglia projecting posteriorly from behind the ear (Figure 2E). As these tumors grew larger,
they clearly overtook the entire ganglia and tracked along nerves, for example those leaving
the skull and projecting towards the ear or behind the eye (Figure 2F). These tumors did not
appear to be ganglioneuromas as they did not produce ganglion cells as they grew. Thus, based
upon the origin of these tumors in ganglia as well as their histological appearance, we suspected
that they were neuroblastomas. By staining with the pan-neural marker HuC we confirmed that
these tumors were of neural origin (Figure 2G-H). However, the tumors failed to stain for
tyrosine hydroxylase (Figure 2I). This marker is expressed in the catecholaminergic neurons
of the peripheral sympathetic nervous system that are most often the cell of origin for human
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neuroblastoma (17,18). So while these tumors were unquestionably neural and histologically
resemble human neuroblastoma, they did not appear to arise from the same population of
neurons that contributes to most human neuroblastoma. However, they may share other
characteristics with the human disease.
Neuroblastoma is usually a neonatal or childhood cancer in humans. Tumors of this class
typically orginate from a precursor/progenitor population that persists inappropriately because
of a failure to instigate the normal differentiation and/or apoptotic program (18,19). In order
to determine the origin of the tumors in Hag zebrafish, we conducted a time course analysis
of the progeny of Hag heterozygous crosses (including wild type, heterozygous, and
homozygous sibs) by analyzing a subset of each cohort at one-month intervals. The cranial
ganglia of one-month-old fish contained clusters of cells that appeared very similar in size,
shape, and organization to the tumor cells (Figure 3A-B). These were found in both wild type
and mutant fish, and thus we conclude that this is a normal developmental stage. However, by
two months of age, these cells appeared less frequently and are fewer in number in wild type
fish than in either heterozygous or homozygous Hag fish (data not shown). This was even more
apparent at three months, by which time these cells were completely absent in the wild type
fish, but they were maintained within almost all of the heterozygous and homozygous Hag
mutants (Figure 3C-D, Table 2). These cells were neural as they strongly express HuC (Figure
3E-H). Taken together, these data suggest that the presence of this cell population in the wild
type zebrafish denotes a stage of neuronal development that is normally completed before 3
months of age. The simplest explanation of this finding is that these cells represent a neural
precursor population. We believe that the persistence of these cells in 3 month old Hag mutants
is an early event in the tumorigenic process. Notably, these small neoplasias occurred at a
similar frequency in both heterozygous and homozygous Hag mutants.
By as early as 5 months these neoplasias began to grow into advanced tumors in a small
proportion of Hag fish, spreading throughout entire ganglia and following nerve bundles away
from their site of origin (Fig 3I-J). These advanced tumors emerged at a slightly higher rate in
homozygotes than in heterozygotes (Table 2). However, our ability to track the tumor
development in homozygotes was compromised by an additional phenotype of the homozygous
fish; with variable penetrance they develop severe inflammation in the wall of the posterior
esophagus and anterior gut, leading to wasting and eventual mortality, possibly due to
starvation (Table 2, Figure S1). Taken as a whole, this time course experiment indicates that
heterozygotes and homozygotes have a similar propensity to inappropriately maintain this
presumed precursor cell population but these neoplasias develop into more advanced tumors
at a somewhat faster rate in homozygous versus heterozygous Hag mutants.
Hag mutations upregulate fgf8 expression rather than affect fbxw4
We wished to determine how the Hag mutant alleles contribute to the tumorigenic state. The
insertional mutants used in this screen were made with Moloney Murine Leukemia Virus
(MoMLV)-based vectors. In mammals, MoMLV insertions can cause either gene activation
through enhancer activity of the viral LTRs or inactivation by disruption of splicing or coding
sequences (20,21). Most of the mutants we recovered in our screen were recessive (491/497),
and we isolated only six dominant mutations that represent insertions in three different loci
(12,14, A.A. and N.H. unpublished data). Molecular analysis demonstrates that in all of the
recessive mutations that we have examined, expression of the gene in which the insertion lies
is reduced or abrogated (11,13,22, A.A. and N.H. unpublished data). In contrast, the cause of
the dominant mutations is less clear; they could be loss-of-function alleles of haploinsufficient
loci or gain-of-function alleles.
To understand why the Hag mutants are tumor-prone, we first examined if expression of the
fbxw4 gene was affected, as all of the insertions lie within this gene, hiD2058 at the splice
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donor of the first exon and hiD1, hiD2 and hiD4000 all in the fifth intron (Figure 4A). We
chose to analyze gene expression in homozygotes as this would facilitate the detection of gene
expression changes in cis to the insertion, especially if the effect was down-regulation. We
used real time reverse transcriptase polymerase chain reaction (RTPCR) on RNA isolated from
whole fish. We examined expression of fbxw4 in wild type fish and homozygotes for three of
the lines at two developmental stages: the end of embryogenesis (5 days) and after juvenile
morphogenesis (6 weeks), when the pigment phenotype that is the defining characteristic of
the Hag mutants is clearly visible (Figure 4B). For hiD2058, the mutant with an insertion at
the splice donor of the first exon, expression was reduced to approximately 1% of wild type
levels (Figure 4B). Additional analysis indicated that this insertion interferes with the splicing
of the message, utilizing a cryptic splice site in the first exon upstream of the initiation codon
(data not shown). Thus for hiD2058, the level of fbxw4 is greatly reduced and also incapable
of producing full-length protein, if any protein at all. However, for two of the lines with
insertions in the fifth intron (hiD1 and hiD4000), there was no change in level of fbxw4 mRNA
at either of these time points (Figure 4B). Since all of the alleles have the same phenotype (both
pigment and tumor phenotypes) but at least two of the three alleles with insertions in the large
intron do not affect fbxw4 expression (expression in hiD2 was not examined), it is unlikely
that the loss of fbxw4, even in hiD2058, is responsible for any of the observed phenotypes.
The gene immediately upstream of fbxw4 is fgf8 (Figure 4A), and this juxtaposition is
conserved between fish and mammals. Fgf8 is a common site for mouse mammary tumor virus
(MMTV) insertions in murine mammary cancer, where viral insertions lead to fgf8
overexpression (23-25). There are even some reported cases where MMTV had inserted in the
murine fbxw4 gene to cause activation of fgf8 (25). Although we have not previously seen the
MoMLV virus activate genes in zebrafish, given the mouse results we thought it would be
prudent to examine the effects of these insertions upon fgf8 expression in a manner identical
to that used for fbxw4. During embryogenesis, fgf8 expression is very dynamic and its function
is especially important, as both loss-of-function mutants and mutations that lead to fgf8
overexpression have early embryonic phenotypes (26,27). In wild type fish, fgf8 expression
declines after embryogenesis (Figure 4C) though it is known to remain expressed in some
tissues (28,29). During embryogenesis, we did not see any difference in fgf8 mRNA levels
between whole wild type fish and Hag homozygotes (Figure 4C). However, at six weeks of
age, fgf8 mRNA levels were 6−12 times higher in Hag homozygotes than in wild type controls
for all three lines tested (Figure 4B). To further explore this deregulation, we examined fgf8
mRNA levels in wild type and homozygous fish over a number of intervening time points for
one allele (hiD4000, Figure 4C). In wild type fish, the overall level of fgf8 mRNA began to
decline 1−2 weeks after embryogenesis was complete and fgf8 mRNA dropped to very low
levels by 5−6 weeks of age. In contrast, the amount of fgf8 mRNA was maintained at near-
embryonic levels in Hag homozygotes throughout the time course. Notably, there is an
excellent correlation between the loss or maintenance of fgf8 mRNA in the wildtype and
Hag mutant fish and the loss or maintenance of the presumed neural precursor population.
Importantly, the timeframe of fgf8 downregulation precedes the loss of the putative precursor
cells in wild type fish suggesting that high fgf8 somehow contributes to the maintenance of
this population in the Hag mutants. As expression was measured from RNA prepared from
whole fish, it is not clear if this difference is the result of higher levels of fgf8 in cells that
normally express it or ectopic expression of fgf8. Nonetheless, it is clear that fgf8 is dramatically
upregulated in Hag mutants and that it is likely fgf8, not fbxw4, which is the gene responsible
for the Hagoromo phenotypes. Consistent with this hypothesis, we note that an enhancer trap
screen using another MoMLV-based retrovirus (30) has yielded two insertions, CLGY1030
and CLGY508 (31), that lie in intergenic sequences upstream and downstream of fgf8,
respectively (fig 4A). Analysis of fgf8 expression in these mutants revealed both increased
fgf8 expression in the midbrain-hindbrain boundary at 3 dpf and ectopic fgf8 expression in the
spinal region of 35 dpf fish, and these two mutants develop a stripe phenotype that is highly
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reminiscent of our Hagoromo mutants (A.Z.K and T.S.B., unpublished data). Histological
analysis of these lines show that they also develop neuroblastoma tumors (Figure S2). Taken
together, these data strongly suggest that the tumor predisposition in these six lines result from
a failure to downregulate fgf8 subsequent to embryogenesis and the consequent persistence of
a putative neuronal precursor population.
As a further test of this hypothesis, we wished to determine if increased fgf8 expression occurs
in the region of the cranial ganglia where the tumors originate. Thus we analyzed fgf8
expression by both semi-quantitative RT-PCR and real-time RT-PCR on mRNA from several
parts of the head of wild type and both heterozygous and homozygous Hag fish at 3 months
of age, the time at which the clusters of neural precursors are first completely absent in wild
type fish but maintained in the Hag mutants. The tissues analyzed included the brain, the skull,
the soft tissue ventral to the skull (which included the cranial ganglia), and the jaws and skin.
Of these tissues, the brain had the highest overall fgf8 expression in wild type fish, and fgf8
expression appeared slightly higher in the brain of Hag mutants. The other three tissues, where
fgf8 was expressed at a low level in wild type fish, showed dramatically higher levels of fgf8
in Hag mutants (Figure 5A). Thus, we conclude that elevated fgf8 expression is not restricted
to the cranial ganglia but is clearly present in this region of the Hag mutants. Most importantly,
in situ hybridization with antisense fgf8 probe on sections cut from fish with tumors shows
robust expression of fgf8 in most, although not all, cells in the tumor (Figure 5B-C). Thus, we
conclude that the neuroblastomas themselves express fgf8 at a very high level.
DISCUSSION
Through the unbiased histological screening of a collection of zebrafish insertional mutants,
we determined that four independent lines carrying mutations in the Hagoromo locus develop
neuroblastoma-like tumors at high penetrance. In some regards, these tumors are quite different
than human neuroblastoma, which arises from neural crest-derived neural precursors in the
sympathetic nervous system and grow predominantly in the abdomen or neck (17,18). Tumors
in Hagoromo fish arise in cranial ganglia and grow in the head. While they are clearly of neural
origin, as judged by their expression of HuC, these zebrafish tumors do not express markers
of catecholaminergic neurons indicating that they are derived from a different neural lineage
than human neuroblastoma. Despite this difference, the Hagoromo tumors seem to arise
through a similar mechanism as the human disease. Specifically, human neuroblastoma
typically arises in infants and is thought to be a tumor of embryonic origin, i.e. derived from
neural precursors present during fetal development (18,19). Our analysis shows that wildtype
zebrafish have a population of cells which exists in the cranial ganglia of juvenile fish but is
lost as the fish grow to adulthood. We hypothesize that these cells represent neural precursors
and their disappearance, presumably through differentiation or apoptosis, reflects the normal
developmental program. These cells are inappropriately maintained in Hagoromo mutants and
they are the originating cell of the Hagoromo mutant tumors. While in many cases these clusters
of cells fail to grow past the size of small neoplasias, in 10−20% of the mutants they eventually
grow into advanced tumors beginning as early as five months. This stochastic event likely
reflects the need to acquire additional mutations within these cells. The Hagoromo mutation
seems to act by prolonging the existence of, and possibly driving the expansion of, this target
cell population.
The four Hagoromo mutant lines each carry viral insertions in the fbxw4 gene. However, our
data show that they do not have a shared effect on fbxw4 expression: one allele, in which the
insertion lies at the splice donor of the first exon, does diminish fbxw4 mRNA levels, but the
other insertions, which lie in the fifth intron, have no detectable effect on fbxw4. Instead, our
data suggest that the key consequence of the Hagoromo insertions is to maintain high levels
of fgf8 expression after embryogenesis. Specifically, we find that fgf8 mRNA is dramatically
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upregulated in Hagoromo mutants after the completion of embryonic development, including
expression in the head region where the inappropriately maintained precursors are first
observed. In addition, very high fgf8 expression is seen in the tumors themselves. Finally,
insertional mutants have been recovered with a related virus from a different screen with
phenotypes including both the stripe phenotype and the neuroblastoma phenotype in which the
insertions lay outside of fbxw4, either between fgf8 and fbxw4 or upstream of fgf8, distal to
fbxw4.
The mechanism by which these insertions activate fgf8 expression is unclear. That the gene
containing the viral insertions is not truly the affected gene should serve as a cautionary
example for the analysis of other insertional mutants. In this case, although we cannot rule out
direct viral activation, our previous studies suggest that the MoMLV LTR does not activate
transcription in zebrafish cells; viruses relying upon the LTR to drive expression of the lacZ
gene produced no ß-galactosidase activity while viruses with an internal promoter driving
lacZ were able to do so (32). Additionally, in all other cases where the expression of genes at
the site of MoMLV insertions in zebrafish has been examined, gene expression has either
decreased or been unaffected (11,13,22,33). Thus, we instead favor the notion that the virus
disrupts the transcriptional control of fgf8 by distal cis-acting elements. This hypothesis is
supported by several lines of evidence showing that fgf8 expression is controlled by a number
of enhancers upstream, within, and downstream of the gene, including elements within the
fbxw4 gene (31,34,35). Additionally, retroviral insertions in the Fgf8/Fbxw4 locus in the mouse
(36-37) or genomic duplications near FGF8 in humans (38-39) cause a limb outgrowth
phenotype (dactylaplasia or split hand foot malformation). The mechanism of these mouse and
human mutations is not understood. However, the mouse mutants have been shown to have a
defect in the maintenance of the apical ectodermal ridge (AER) of the developing limb, and
Fgf8 expression is normal at the beginning of limb development but is quickly lost (36). While
it has been suggested that this altered Fgf8 expression is a secondary consequence of AER loss,
it also seems possible that the insertions in the mouse dactylaplasia mutants affect fgf8
expression in a direct, but complex, way that somehow accounts for the observed
downregulation after limb development begins. Although the molecular and phenotypic
consequences of insertions and chromosomal rearrangements of the Fgf8/Fbxw4 locus clearly
differ between mammals and fish, it seems plausible that the resulting phenotypes in each
organism (limb outgrowth defects in mammals, maintenance of neural precursor cells and
stripe disruption in zebrafish) can be accounted for by differential effects upon fgf8 expression.
Regardless of the mechanism by which the zebrafish insertions cause continued high levels of
fgf8 expression after embryogenesis, it clearly leads to the inappropriate maintenance and
expansion of a putative neural precursor population that ultimately become tumors. We note
that the increase in fgf8 expression in the head region of Hagoromo fish occurs at a time when
this cell population diminishes in wild type fish. This suggests that fgf8 is capable of
contributing to the maintenance of these cells, either by blocking differentiation or promoting
survival. It would seem paradoxical that fgf8 should prevent differentiation of these precursor
cells as many studies have associated fgf8 with neural differentiation. A requirement for fgf8
in the development of neurons in various areas of both the central and peripheral nervous
system, including the epibranchial placodes that give rise to the cranial ganglia, has been
demonstrated both in zebrafish, (40-42) and in mice (43). Furthermore, Fgf8 cooperates with
retinoic acid to force mouse embryonic carcinoma P19 cells to differentiate into neurons while
inhibition of fgf signaling in this cell culture system attenuates neural differentiation (44).
However, this pro-differentiation role for fgf8 might be restricted to specific developmental
stages such as embryogenesis. For example, in some settings fgf8 signaling can promote
proliferation of neural precursors at the expense of differentiation (45). The other possibility,
that fgf8 acts as a pro-survival signal for these cells, is supported by the observation that several
fgfs, including fgf8, have anti-apoptotic functions in both neural crest and ectoderm-derived
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neurons (43,46). The effects of fgf8 upon differentiation and survival may depend upon timing
and context, such that early in development neural differentiation is the favored response, but
sustained fgf8 expression past the time when such differentiation normally occurs may result
in inappropriate survival and/or proliferation of the few remaining neural precursor cells.
Thus fgf8 appears to be an oncogene, in that its overexpression predisposes zebrafish to
tumorigenesis. However, the tumor phenotype in Hagoromo mutants is not fully penetrant.
Notably, it appears that fgf8 overexpression in Hagoromo mutants is always sufficient to disrupt
the orderly alignment of pigment cells (which are moving into their stripe pattern at the time
when we first see fgf8 overexpression in the mutants), as well as the inappropriate maintenance
of putative neural precursor cells in cranial ganglia. However, these only progress to tumors
in a subset of cases, suggesting that additional mutations are required. It is possible that there
is only a limited window of opportunity for the precursor cell population to acquire these
changes. This model is supported by our finding that small neoplasias exist in nearly all of the
mutants at 3−6 months of age (and we might miss some due to sampling only three sections
per fish) but are detected in fewer than half of the fish at two years of age. Thus, we speculate
that fgf8 overexpression allows for the persistence of a cell population that is then a target for
additional mutations, and there may be a limited time in which such mutations can contribute
to tumorigenesis. We do not currently know what these additional mutagenic events are, and
this is an important question for future study. However, we believe it is unlikely that mutation
of the tumor suppressor gene p53 is one such key event, as fish mutant for both Hagoromo and
p53 (3) do not have a higher rate of neuroblastoma formation by one year of age than fish
mutant for Hagoromo alone (data not shown).
Fgf8 has also been implicated in tumorigenesis in other tumor types in mammals.
Overexpression of FGF8 has been observed in a number of human tumors, especially prostate
and breast cancer (47-49). Furthermore, whole genome association studies indicate that specific
polymorphisms in the fgf receptor FGFR2 correlate with an increased frequency of breast
cancer (50,51). Direct evidence for the oncogenic properties of Fgf8 in these tissues is even
clearer in mice. The Fgf8 locus is a common insertion site for MMTV in retrovirus-induced
mammary tumors (23-25), implying that its activation in mammary tissue can lead to
tumorigenesis. Additionally, transgenic tissue-specific overexpression of Fgf8 cooperates with
Pten loss in mouse models of prostate cancer (52). Thus, FGF8 appears to function as oncogene
in numerous settings including prostate and breast cancer in mammals, and now neuroblastoma
in zebrafish.
MATERIALS AND METHODS
Fixation and Histology
Adult fish were euthanized in 500mg/L Tricaine and fixed in either Bouin's fixative or 10%
neutral buffered formalin (in cases where we wished to retain the option of
immunohistochemistry or in situ hybridization). Embedding in paraffin and sectioning were
performed as previously described (2,53). Prior to fixation a piece of tail tissue was retained
for the isolation of genomic DNA and either Southern analysis or PCR was conducted to
determine the genotype of fish from the Hag heterozygous crosses (54).
Antibody staining
Slides from fish fixed in 4% paraformaldehyde/PBS and paraffin embedded were stained as
previously described (55). Primary antibodies used were anti-TH (P40101−0, 1:100, Pel-Freez,
Rogers AR) and anti-HuC (16A11, 1:250, Molecular Probes, Eugene OR)
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RNA In Situ Hybridization
Dig-labeled riboprobes were produced for both sense and antisense strands of the coding
regions of the zebrafish fgf8 and HuC genes using a dig-labeling kit (Roche 11175033910)
Slides from fish fixed in 4% paraformaldehyde/PBS and paraffin embedded were dewaxed
(55), rinsed with PBS, treated with Proteinase K (40 μg/ml) for 7 min, rinsed with PBS, refixed
in 4% paraformaldehyde/PBS for 20 min, rinsed with PBS, andrinsed twice in 2X SSC. They
were then prehybridized in hybridization solution (50% formamide, 5X SSC, 0.1% Tween, 1
mg/ml tRNA, 50 μg/ml heparin) for 3 hours at 70°C, and hybridized overnight at 70°C in a
humid box with 100 μl hybridization solution plus probe (1 μg/ml) under a cover slip. Slides
were washed at 70°C for 10 min with 75% hyb/25% 2X SSC, 50% hyb/50% 2X SSC, 25%
hyb/75% 2X SSC, 2X SSC, and for 30 min with 0.2X SSC. Slides were equilibrated in MAB
+ 0.1% tween for 30 min, blocked MAB + 0.1% tween + 10% lamb serum + 2% blocking
reagent (Roche 11096176001) then AP-conjugated anti-DIG Fab fragments were applied
(1:1000, Roche 11093274910) overnight at 4°C. Antibody was washed 5 × 30 min in MAB +
0.1% Tween, and AP activity was detected with NBT/BCIP as recommended by the
maufacturer (Roche, 11383213001 and 11383221001). Figures show results with antisense
probes; no blue stain was observed with sense-strand probes of simultaneously processed
adjacent-level slides.
Quantitative RNA analysis
RNA was prepared from embryos, adult fish tissues, or whole juvenile fish using Trizol reagent
(Invirtrogen, Carlsbad CA); in the case of whole fish 17dpf or older, fish were flash-frozen in
liquid nitrogen and mashed in a mortar and pestle prior to homogeniztion in Trizol. First strand
cDNA was prepared using Superscript III reverse transcriptase (Invirtrogen, Carlsbad CA) and
gene expression levels were determined using real time PCR with Sybr Green Master Mix
(ABI). Standard curves were established for each primer set with cDNA dilutions and all
samples were run in triplicate and normalized with primers for gapdh. All primer sequences
are available upon request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Distibution of types of tumorigenic lesions in the background population.
Amsterdam et al. Page 13
Mol Cancer Res. Author manuscript; available in PMC 2010 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Neuroblastoma-like tumors in Hag heterozygotes at two years of age. A. (40X) a very advanced
tumor fills most of the head space between the esophagus and the skull and invades the body
wall musculature; B-C. (400X) rosette arrangement of cells is occasionally observed in tumors
(B) but more commonly cellular arrangement is more variable (C); D-E. (400X) very small
neoplasias (black arrowheads) observed in the ganglia within the skull below the midbrain (D)
or posterior of the ear (E); F. (100X) this tumor can be seen growing along the nerve running
behind the eye as well as another below the skull; G-I. (200X) H&E (G), anti-HuC (H), and
anti-TH (I) of the same tumor; inset in I shows TH staining of adrenal cells in the kidney on
the same slide as a positive control for the antibody.
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Figure 3.
Tumors begin as inappropriate maintenance of a normal developmental stage of putative neural
precursors. A-B. (400X) at 4 weeks small cells resembling the tumor cells (asterisks) are seen
in cranial ganglia of both wild type (A) and Hag (B) fish; C-D. (400X) at 12 weeks, only fully
developed ganglion cells are observed in wild type fish (C), but the small precursor-like cells
(black arrowheads) are still observed in most Hag mutants (D). E-H. (200X) the small cells
seen uniquely in Hag mutants (black arrowheads) at 12 weeks (F) stain strongly for HuC mRNA
by in situ hybridization (H); ganglion cells in wild type (E) and Hag mutants (F) stain weakly
for HuC (G,H); I. (400X) tumor beginning to spread over entire ganglia in 24 week Hag
Amsterdam et al. Page 15
Mol Cancer Res. Author manuscript; available in PMC 2010 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
heterozygote; J. (100X) tumor in 31 week homozygote growing within the skull and along
nerves behind and above the eye.
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Figure 4.
Hag mutations are insertions in the fbxw4 gene but affect expression of the neighboring fgf8
gene. A. Location of the mutagenic insertions in Hag mutants. hiD2058 is precisely at the splice
donor of exon 1 of fbxw4; the other three insertions are in the 24 kb fifth intron. Enhancer trap
insertions CLGY1030 and CLGY508 are in intergenic sequence upstream and downstream of
fgf8, respectively. B. fbxw4 and fgf8 mRNA measured in whole fish by real-time RT-PCR in
wild type and homozygotes of multiple Hag alleles at 5 and 41 days. Units are normalized to
wild type sample of each developmental age. C. fgf8 mRNA measured in whole fish by real-
time RT-PCR in wild type and hiD4000 homozygotes from 3 to 41 days. Units are normalized
to the 3 day wild type sample. For B and C, error bars show the standard deviation of 2−3
technical replicates.
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Figure 5.
Hag mutants overexpress fgf8 in the head region of young adults and in tumors A. fgf8 mRNA
in multiple parts of the head of 3 month old wild type, hiD2058 heterozygote and hiD2058
homozygote fish were measured by real-time and semi-quantitative RT-PCR; gapdh was used
as a normalization control. Samples were isolated from three (brain) or four wild type fish and
two each Haghi2058 heterozygotes and homozygotes. Ethidium bromide stained gels from semi-
quantitative RT-PCR are shown on the left; quantification of the real-time PCR is shown on
the right. Quantification is normalized within the dataset for each tissue to the average wild
type sample of that tissue; error bars show the standard deviation of three technical replicates.
B-C. (20X) H&E (B) and fgf8 in situ hybridization (C) on a very advanced tumor in a 2 year
old hiD2058 homozygote.
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Table 1
Incidence of neuroblastoma in 2 year old Hag heterozygotes and their wild type siblings
Allele Wild type Heterozygote
hiD1 Total tumors 0/34 16/34 (47%)
Small neoplasias 0/34 7/34 (21%)
Advanced tumors 0/34 9/34 (26%)
hiD2 Total tumors 0/56 19/77 (25%)
Small neoplasias 0/56 19/77 (25%)
Advanced tumors 0/56 0/77
hiD2058 Total tumors 0/39 17/38 (45%)
Small neoplasias 0/39 13/38 (34%)
Advanced tumors 0/39 4/38 (11%)
hiD4000 Total tumors 0/24 18/59 (30%)
Small neoplasias 0/24 9/59 (15%)
Advanced tumors 0/24 9/59 (15%)
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